CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.370
+0.080 (2.43%)
Aug 25, 2026, 4:00 PM EDT - Market closed
CytomX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.22 | 12.67 | 38.05 | 17.17 | 193.65 | 205.53 |
Short-Term Investments | 313.06 | 124.39 | 62.57 | 157.34 | - | 99.7 |
Cash & Short-Term Investments | 330.28 | 137.05 | 100.62 | 174.51 | 193.65 | 305.23 |
Cash Growth | 108.92% | 36.20% | -42.34% | -9.88% | -36.55% | -3.45% |
Receivables | 38.99 | 2.01 | 3.1 | 3.43 | 35.99 | 0.79 |
Prepaid Expenses | 2.96 | 4.86 | 3.58 | 5 | 7.47 | 4.29 |
Total Current Assets | 373.16 | 143.92 | 107.31 | 182.94 | 237.1 | 310.3 |
Property, Plant & Equipment | 6.12 | 4.7 | 10.6 | 16.18 | 21.02 | 25.32 |
Goodwill | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
Other Intangible Assets | 0.37 | 0.44 | 0.58 | 0.73 | 0.88 | 1.02 |
Other Long-Term Assets | 0.64 | 1.56 | 1.09 | 1 | 0.94 | 1.82 |
Total Assets | 381.23 | 151.57 | 120.53 | 201.79 | 260.89 | 339.41 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.94 | 1.3 | 1.09 | 1.46 | 2.81 | 2.82 |
Accrued Expenses | 12.35 | 14.17 | 12.34 | 17.6 | 22.82 | 30.62 |
Current Portion of Leases | 1.5 | 4.24 | 5.15 | 4.59 | 4.08 | 3.62 |
Current Unearned Revenue | 24.07 | 26.88 | 67.2 | 132.27 | 121.27 | 40.82 |
Other Current Liabilities | - | 0.02 | - | - | 1.63 | - |
Total Current Liabilities | 39.86 | 46.62 | 85.77 | 155.91 | 152.61 | 77.87 |
Long-Term Leases | 4.21 | - | 4.24 | 9.39 | 13.98 | 18.06 |
Long-Term Unearned Revenue | 30.62 | 1.59 | 26.86 | 80.05 | 180.06 | 243.94 |
Other Long-Term Liabilities | 4.47 | 4.35 | 4.12 | 3.89 | - | - |
Total Liabilities | 79.16 | 52.56 | 120.99 | 249.24 | 346.64 | 339.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 1,053 | 810.84 | 691.1 | 675.91 | 637.12 | 623.34 |
Retained Earnings | -750.86 | -711.95 | -691.58 | -723.45 | -722.88 | -623.56 |
Comprehensive Income & Other | -0.2 | 0.11 | 0.03 | 0.1 | 0.01 | -0.24 |
Shareholders' Equity | 302.07 | 99.01 | -0.46 | -47.45 | -85.75 | -0.46 |
Total Liabilities & Equity | 381.23 | 151.57 | 120.53 | 201.79 | 260.89 | 339.41 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5.7 | 4.24 | 9.39 | 13.97 | 18.06 | 21.67 |
Net Cash (Debt) | 324.58 | 132.81 | 91.24 | 160.54 | 175.59 | 283.55 |
Net Cash Growth | 114.66% | 45.57% | -43.17% | -8.58% | -38.07% | -2.64% |
Net Cash Per Share | 1.77 | 0.96 | 1.08 | 2.18 | 2.67 | 4.42 |
Filing Date Shares Outstanding | 217.9 | 170.19 | 80.1 | 67.72 | 66.23 | 65.39 |
Total Common Shares Outstanding | 217.9 | 170.19 | 80.1 | 67.31 | 66.23 | 65.39 |
Working Capital | 333.29 | 97.31 | 21.53 | 27.02 | 84.49 | 232.43 |
Book Value Per Share | 1.39 | 0.58 | -0.01 | -0.70 | -1.29 | -0.01 |
Tangible Book Value | 300.75 | 97.62 | -1.99 | -49.13 | -87.58 | -2.43 |
Tangible Book Value Per Share | 1.38 | 0.57 | -0.02 | -0.73 | -1.32 | -0.04 |
Machinery | - | 16.62 | 16.69 | 16.3 | 17 | 17.75 |
Construction In Progress | - | - | - | 0.37 | 0.71 | 0.31 |
Leasehold Improvements | - | 1.6 | 2.01 | 1.98 | 1.74 | 1.74 |